Category: MS Research Study and Reports

Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials

 Jinchi Jiang,‡a   Chuanqi Chu,‡a   Caie Wu,b   Chen Wang,ac   Chengcheng Zhang,ac   Tiantian Li,ac   Qixiao Zhai,  acd   Leilei Yu,*ac   Fengwei Tian  *ac  and  Wei Chen  acef    Author affiliations Abstract Preliminary evidence shows the potential role…

Stuart Schlossman

Study protocol on advance care planning in multiple sclerosis (ConCure-SM): intervention construction and multicentre feasibility trial

 August 13, 2021   – Pubmed Abstract Introduction: Multiple sclerosis (MS) is the most common cause of progressive neurological disability in young…

Stuart Schlossman

What is happening to people with MS on DMTs getting vaccinated with the COVID-19 vaccines. Are they immune or not?

  Gavin Giovannoni Jul 16 Yes, we are seeing vaccine breakthroughs in vaccinated patients with MS on ocrelizumab. A colleague…

Stuart Schlossman

Trial Will Test Mavenclad for Advanced Progressive MS

 After some delays due to the COVID-19 pandemic, the Phase 2/3 clinical trial evaluating whether Mavenclad (cladribine) can slow hand and arm…

Stuart Schlossman

Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls

  Enrique Alvarez 1, Kavita V Nair 2, Brian D Hoyt 3, Rebecca A Seale 1, Stefan Sillau 1, Augusto Miravalle 4, Eric Engebretson 1, Brittany Schurr 1, John R Corboy 1, Timothy L Vollmer 1, Justin M Honce 5 Affiliations …

Stuart Schlossman

Biogen Announces Results from Phase 3b NOVA Study Evaluating Every Six-Week Dosing with Natalizumab in Relapsing-Remitting Multiple Sclerosis

 AUGUST 2, 2021 •                     Results show that every six-week natalizumab IV administration…

Stuart Schlossman

Could BTK Inhibitors Be the Next Big MS Treatment?

 by Ed Tobias | July 30, 2021  – The MS Wire Is orelabrutinib one of the next big MS therapies? Biogen…

Stuart Schlossman

Signaling Protein Seen to Help Promote Myelin-making Cells

 by Marisa Wexler MS | July 28, 2021 A signaling protein called fractalkine helps to regulate the development of oligodendrocytes, cells of the…

Stuart Schlossman

• Gray Matter in Hippocampus Can Help Distinguish Between Two MS Types

 by Marisa Wexler MS | July 27, 2021 Subtle changes in structure in the hippocampus — a region of the…

Stuart Schlossman

Considerations for the Use of Fumarates in Relapsing MS

 July 24, 2021 Fred D. Lublin, MD, Ravi Dukkipati, MD, Gavin Giovannoni, MD , Lauren Gluck, MD CLICK IMAGE TO…

Stuart Schlossman

Categories

Latest Blog Posts